In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify cannabis for a Agenda III drug. This rescheduling will acknowledge that cannabis has legitimate healthcare functions and will help open the door to analysis on other prospective procedure takes advant